Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 2446 AL 2460

Apolipoprotein E ϵ4 allele and neuropsychiatric symptoms among older adults in Central Africa (EPIDEMCA study)

Yoro-Zohoun I, Houinato D, Nubukpo P, Mbelesso P, Ndamba-Bandzouzi B, Lambert JC, Clément JP, Dartigues JF, Preux PM, Guerchet M.

Int Psychogeriatr. 2021 Mar;33(3):295-306. doi: 10.1017/S1041610220003993. Epub 2021 Mar 15.

Are people with mild dementia able to (re)learn how to use technology? A literature review

Kerkhof YJF, Bergsma A, Mangiaracina F, Planting CHM, Graff MJL, Dröes RM.

Int Psychogeriatr. 2022 Feb;34(2):113-128. doi: 10.1017/S1041610221000016. Epub 2021 Mar 15.

A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease

Rosenbloom M, Barclay TR, Kashyap B, Hage L, O'Keefe LR, Svitak A, Pyle M, Frey W, Hanson LR.

Drugs Aging. 2021 May;38(5):407-415. doi: 10.1007/s40266-021-00845-7. Epub 2021 Mar 15.

The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow

Beishon LC, Panerai RB, Budgeon C, Subramaniam H, Mukaetova-Ladinska E, Robinson TG, Haunton VJ.

J Alzheimers Dis. 2021;80(4):1567-1581. doi: 10.3233/JAD-201444.

Temporal Trends in Stroke-Related Memory Change: Results From a US National Cohort 1998-2016

Eng CW, Mayeda ER, Gilsanz P, Whitmer RA, Kim AS, Glymour MM.

Stroke. 2021 May;52(5):1702-1711. doi: 10.1161/STROKEAHA.120.031063. Epub 2021 Mar 16.

Hypertension-related risk for dementia: A summary review with future directions

Daugherty AM.

Semin Cell Dev Biol. 2021 Aug;116:82-89. doi: 10.1016/j.semcdb.2021.03.002. Epub 2021 Mar 12.

Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes-Mediated Alzheimer's Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin

Khan MS, Ikram M, Park TJ, Kim MO.

Oxid Med Cell Longev. 2021 Feb 27;2021:4051207. doi: 10.1155/2021/4051207. eCollection 2021.

Experimentally evoked pain in Alzheimer's disease

Anderson AR, Iversen WL, Carter MA, Moss KO, Cowan RL, Monroe TB.

J Am Assoc Nurse Pract. 2021 Mar 12;34(1):18-25. doi: 10.1097/JXX.0000000000000580.

Functional autonomy in dementia of the Alzheimer's type, mild cognitive impairment, and healthy aging: a meta-analysis

Altieri M, Garramone F, Santangelo G.

Neurol Sci. 2021 May;42(5):1773-1783. doi: 10.1007/s10072-021-05142-0. Epub 2021 Mar 18.

Associations between coronary heart disease and risk of cognitive impairment: A meta-analysis

Liang X, Huang Y, Han X.

Brain Behav. 2021 May;11(5):e02108. doi: 10.1002/brb3.2108. Epub 2021 Mar 20.

Optimizing clinical phenotyping to better delineate the complex relationship between type 2 diabetes and Alzheimer's disease

Hanson AJ, Rubinow KB.

Clin Transl Sci. 2021 Sep;14(5):1681-1688. doi: 10.1111/cts.13024. Epub 2021 Mar 24.

The outcomes of a person-centered, non-pharmacological intervention in reducing agitation in residents with dementia in Australian rural nursing homes

Isaac V, Kuot A, Hamiduzzaman M, Strivens E, Greenhill J.

BMC Geriatr. 2021 Mar 20;21(1):193. doi: 10.1186/s12877-021-02151-8.

Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry

Wakisaka Y, Matsuo R, Nakamura K, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.

Cerebrovasc Dis. 2021;50(4):390-396. doi: 10.1159/000514368. Epub 2021 Mar 19.

Modifiable Risk Factors Associated with Alzheimer's Disease with Special Reference to Sleep Disturbance

Chauhan PS, Mishra M, Koul B, Sharma M, Yadav D.

CNS Neurol Disord Drug Targets. 2021;20(7):594-601. doi: 10.2174/1871527320666210319111852.

Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies

Ashraf GM, Ebada MA, Suhail M, Ali A, Uddin MS, Bilgrami AL, Perveen A, Husain A, Tarique M, Hafeez A, Alexiou A, Ahmad A, Kumar R, Banu N, Najda A, Sayed AA, Albadrani GM, Abdel-Daim MM, Peluso I, Barreto GE.

Oxid Med Cell Longev. 2021 Mar 5;2021:4572471. doi: 10.1155/2021/4572471. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias